Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vittorio Meneghini
Fludarabine Plus Cyclophosphamide and Rituximab in Waldenstrom Macroglobulinemia
Cancer
Cancer Research
Oncology
Related publications
Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Prognostic Role of CD4 T-Cell Depletion After Frontline Fludarabine, Cyclophosphamide and Rituximab in Chronic Lymphocytic Leukaemia
BMC Cancer
Cancer Research
Oncology
Genetics
The Role of Combined Fludarabine, Cyclophosphamide and Rituximab Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Current Evidence and Controversies
Therapeutic Advances in Hematology
Hematology
Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine
Cancer Management and Research
Oncology
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
Clinical Cancer Research
Cancer Research
Oncology
Waldenstrom Macroglobulinemia Presenting as Plasma Cell Leukemia Associated With Hyperviscosity Syndrome
Medical Science and Discovery
A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenstrom Macroglobulinemia
Clinical Cancer Research
Cancer Research
Oncology
Central Nervous System Involvement by Waldenstrom Macroglobulinemia: A Case Report of the Bing–Neel Syndrome
Case Reports in Hematology
